Article Details

BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the ...

Retrieved on: 2024-10-29 07:40:08

Tags for this article:

Click the tags to see associated articles and topics

BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the .... View article details on hiswai:

Excerpt

... Patentability ("IPRP"), announced by the Company on September 9, 2024. The EPO accepted the Company's claim that the patent family was new, useful ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up